Both in Biotechnology
C4 Therapeutics vs X4 Pharmaceuticals
Over the past year CCCC returned +12.5% and XFOR returned −13.1%; their daily moves had a correlation of 0.31.
CCCC +12.5% XFOR −13.1%Growth of $1, one year, split-adjusted
| Metric | CCCC | XFOR |
|---|---|---|
| Price | $2.98 | $3.25 |
| Market cap | $366.6M | $322.2M |
| Today | −2.61% | +0.31% |
| 1 month | 0.0% | +8.0% |
| 6 months | +5.3% | −22.8% |
| Year to date | +56.0% | −18.8% |
| 1 year | +25.2% | +5.2% |
| Revenue growth (YoY) | +2.8% | +346.3% |
| Gross margin | 100.0% | 81.6% |
| Net margin | −355.9% | −183.5% |
| P/E (TTM) | — | — |
| Price / sales | 10.5× | 20.3× |
| Net cash | $253.7M | $131.2M |
| Dividend yield | — | — |
| Volatility (60d) | 62.1% | 67.2% |
| Short % of float | 43.4% | 9.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).